Charles River Laboratories International, Inc.

NYSE:CRL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 7.52 B

Share Price

USD 152.75

Avg Daily Volume

897,324

Change (1 day)

2.56%

Change (1 year)

-21.39%

Change (YTD)

-17.25%

Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 28, 2025: USD 430.17 M

Charles River Laboratories International, Inc. Depreciation And Amortization is USD 430.17 M for the Trailing 12 Months (TTM) ending June 28, 2025, a 30.03% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.

Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 29, 2024 was USD 330.82 M, a 7.80% change year over year.
Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending July 01, 2023 was USD 306.89 M, a 6.69% change year over year.
Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 25, 2022 was USD 287.65 M, a 15.03% change year over year.
Charles River Laboratories International, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending June 26, 2021 was USD 250.07 M, a 14.68% change year over year.